Literature DB >> 33542446

Cecr2 mutant mice as a model for human cat eye syndrome.

Renée Dicipulo1, Kacie A Norton1, Nicholas A Fairbridge1,2, Yana Kibalnyk1, Sabrina C Fox1, Lisa K Hornberger3, Heather E McDermid4.   

Abstract

Cat eye syndrome (CES), a human genetic disorder caused by the inverted duplication of a region on chromosome 22, has been known since the late 1890s. Despite the significant impact this disorder has on affected individuals, models for CES have not been produced due to the difficulty of effectively duplicating the corresponding chromosome region in an animal model. However, the study of phenotypes associated with individual genes in this region such as CECR2 may shed light on the etiology of CES. In this study we have shown that deleterious loss of function mutations in mouse Cecr2 effectively demonstrate many of the abnormal features present in human patients with CES, including coloboma and specific skeletal, kidney and heart defects. Beyond phenotypic analyses we have demonstrated the importance of utilizing multiple genetic backgrounds to study disease models, as we see major differences in penetrance of Cecr2-related abnormal phenotype between mouse strains, reminiscent of the variability in the human syndrome. These findings suggest that Cecr2 is involved in the abnormal features of CES and that Cecr2 mice can be used as a model system to study the wide range of phenotypes present in CES.

Entities:  

Year:  2021        PMID: 33542446     DOI: 10.1038/s41598-021-82556-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  24 in total

1.  The optic fissure in the normal and microphthalmic mouse.

Authors:  I Hero
Journal:  Exp Eye Res       Date:  1989-08       Impact factor: 3.467

2.  A 600 kb triplication in the cat eye syndrome critical region causes anorectal, renal and preauricular anomalies in a three-generation family.

Authors:  Jeroen Knijnenburg; Yolande van Bever; Lorette O M Hulsman; Chantal A P van Kempen; Galhana M Bolman; Rosa Laura E van Loon; H Berna Beverloo; Laura J C M van Zutven
Journal:  Eur J Hum Genet       Date:  2012-03-07       Impact factor: 4.246

Review 3.  Phenotypic variability of the cat eye syndrome. Case report and review of the literature.

Authors:  P R Rosias; J M Sijstermans; P M Theunissen; C F Pulles-Heintzberger; C E De Die-Smulders; J J Engelen; S B Van Der Meer
Journal:  Genet Couns       Date:  2001

4.  Wide clinical variability in cat eye syndrome patients: four non-related patients and three patients from the same family.

Authors:  S I Belangero; A N X Pacanaro; F T Bellucco; D M Christofolini; L D Kulikowski; R S Guilherme; A Bortolai; A R N Dutra; F B Piazzon; M C Cernach; M I Melaragno
Journal:  Cytogenet Genome Res       Date:  2012-08-10       Impact factor: 1.636

5.  Whole-mount skeletal staining.

Authors:  Diana Rigueur; Karen M Lyons
Journal:  Methods Mol Biol       Date:  2014

Review 6.  Phenotypic variability of Cat-Eye syndrome.

Authors:  M J Berends; G Tan-Sindhunata; B Leegte; A J van Essen
Journal:  Genet Couns       Date:  2001

7.  Minute supernumerary ring chromosome 22 associated with cat eye syndrome: further delineation of the critical region.

Authors:  A J Mears; H el-Shanti; J C Murray; H E McDermid; S R Patil
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

Review 8.  The genetic architecture of microphthalmia, anophthalmia and coloboma.

Authors:  Kathleen A Williamson; David R FitzPatrick
Journal:  Eur J Med Genet       Date:  2014-05-22       Impact factor: 2.708

9.  Murine left atrium and left atrial appendage structure and function: echocardiographic and morphologic evaluation.

Authors:  Francesca Colazzo; Laura Castiglioni; Luigi Sironi; Lucia Fontana; Elena Nobili; Matteo Franzosi; Uliano Guerrini
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

10.  Partial anomalous pulmonary venous return: A case series with management approach.

Authors:  Karim El-Kersh; Elie Homsy; Curt J Daniels; J Shaun Smith
Journal:  Respir Med Case Rep       Date:  2019-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.